Bio-Rad Laboratories, Inc. (BIO)

NYQ – Real vaqt narxi. Valyuta: USD

265.40

-11.13 (-4.02%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

265.40

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 6:28 PM EDT

20.02.2026

International Markets and Bio-Rad (BIO): A Deep Dive for Investors

Examine Bio-Rad's (BIO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

19.02.2026

Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down

BIO misses Q4 EPS estimates as margins shrank and shares slid 12%, despite revenue growth and a rebound in Clinical Diagnostics sales.

13.02.2026

Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript

12.02.2026

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates

Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.51 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.9 per share a year ago.

12.02.2026

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended December 31, 2025. Norman Schwartz, Bio-Rad's Chief Executive Officer, stated: “2025 was a challenging year with geopolitical uncertainty and continued pressure on academic research funding affecting our end markets. While we delivered modest revenue growth and.

29.01.2026

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2025 on Thursday, February 12, 2026, following the close of the market. Management will discuss these results in a conference call scheduled for 2:00 PM Pacific Time (5:00 PM Eastern Time) that day. To participate, dial (800) 715-9871 within the U.S. or (646) 307-196.

21.01.2026

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

Online travel agency Expedia, our top overall contributor in Q4, drove performance in the consumer discretionary sector. Our top performers in the energy and financials sectors were NOV, a provider of oilfield equipment, technology and expertise, and First Citizens, a North Carolina-based bank. Our largest new purchase was Houston-headquartered Prosperity BancShares, the fifth-largest bank in Texas.

Bio-Rad Laboratories, Inc. (BIO)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Bio-Rad Laboratories, Inc. (BIO)

International Markets and Bio-Rad (BIO): A Deep Dive for Investors

Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down

Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

International Markets and Bio-Rad (BIO): A Deep Dive for Investors

Bio-Rad's Q4 Earnings Miss Estimates, Revenues Surpass, Stock Down

Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript

Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

Videolar

No Data

Press-relizlar

Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results

Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference

Bio-Rad Reports Third-Quarter 2025 Financial Results

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025